The burden of respiratory syncytial virus bronchiolitis on a pediatric inpatient service

Israel Medical Association Journal

Volumn 11, Issue 9, 2009, Pages 533-536

  Eidelman, Arthur I ^a,b,c   Megged, Orli ^a,b   Feldman, Roselyn ^a   Toker, Ori ^a,b  

^a SHAARE ZEDEK MEDICAL CENTER   (Israel)

^b HEBREW UNIVERSITY   (Israel)

^c BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Bronchiolitis; Health planning; Respiratory syncytial virus

Indexed keywords

PALIVIZUMAB;

AGE DISTRIBUTION; ARTICLE; CHILD; CONTROLLED STUDY; DATA BASE; FEMALE; HEALTH CARE PLANNING; HOSPITAL ADMISSION; HOSPITAL BED UTILIZATION; HOSPITAL SERVICE; HUMAN; IMMUNOFLUORESCENCE; INFANT; MAJOR CLINICAL STUDY; MALE; MEDICAL DOCUMENTATION; NEWBORN; NOSE SMEAR; NURSING STAFF; PROSPECTIVE STUDY; PULSE OXIMETER; RESOURCE ALLOCATION; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; SEX RATIO; VIRAL BRONCHIOLITIS; WINTER;

AGE FACTORS; BRONCHIOLITIS, VIRAL; CHILD, PRESCHOOL; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, DIRECT; HEALTH PLANNING; HUMANS; INFANT, NEWBORN; INPATIENTS; INTENSIVE CARE UNITS, PEDIATRIC; ISRAEL; LENGTH OF STAY; MALE; RESOURCE ALLOCATION; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RETROSPECTIVE STUDIES; RISK FACTORS; SEASONS;

EID: 70350633874     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Glezen WP, Taber LH, Frank AL, Kasel JA. Risk of primary infection and reinfection with respiratory syncytial virus. Am J Dis Child 1986; 140: 543-546 (Pubitemid 16120909)
2. Leader S, Kohlhase K. Respiratory syncytial virus-coded pediatric hospitalizations. Pediatr Infect Dis J 2002; 21: 629-632 (Pubitemid 34761442)
3. Glezen WP. The changing epidemiology of respiratory syncytial virus and influenza: impetus for new control measures. Pediatr Infect Dis J 2004; 23(11 Suppl): S202-6.
4. Fjaerli HO, Farstad T, Bratlid D. Hospitalizations for respiratory syncytial virus bronchiolitis in Akershus, Norway 1993-2000: a population-based retrospective study. BMC Pediatr 2004; 4: 25.
5. Simoes EA, Carbonell-Estrany X. Impact of severe disease caused by respiratory syncytial virus in children living in developed countries. Pediatr Infect Dis J 2003; 22(2 Suppl): S13-18. (Pubitemid 36230941)
6. Boyce TG, Mellen BG, Mitchel EF Jr, Wright PF, Griffin MR. Rates of hospitalization for respiratory syncytial virus infection among children on Medicaid. J Pediatr 2000; 137: 865-870
7. Heikkinen T, Valkonen H, Lehtonen L, Vainionpaa R, Ruuskanen O. Hospital admissions of high risk infants for respiratory syncytial infection: implication for palivizumab prophylaxis. Arch Dis Child Fetal Neonatal Ed 2005; 90: F64-8. (Pubitemid 40040210)
8. Prais D, Danino D, Schonfeld T, Amir J. Impact of palivizumab on admissions to the ICU for respiratory syncytial virus bronchiolitis: a national survey. Chest 2005; 128: 2765-2771 (Pubitemid 41507638)
9. Shay DK, Holman RC, Newman RD, Liu LL, Stout JW, Anderson LJ. Bronchiolitis-associated hospitalizations among US children, 1980-1996. JAMA 1999; 282: 1440-1446
10. Hall CB, Weinberg GA, Iwane MK, et al. The burden of respiratory syncytial virus infection in young children. N Engl J Med 2009; 160: 588-598
11. Law BJ, Carbonell-Estrany X, Simoes EA. An update on respiratory syncytial virus epidemiology: a developed country perspective. Respir Med 2002; 96(Suppl B): 1-7. (Pubitemid 39665384)
12. Ralston S, Hartenberger C, Anaya T, Qualls C, Kelly HW. Randomized, placebo-controlled trial of albuterol and epinephrine at equipotent beta-2 agonist doses in acute bronchiolitis. Pediatr Pulmonol 2005; 40: 292-299 (Pubitemid 41437605)
13. King VJ, Viswanathan M, Bordley WC, et al. Pharmacologic treatment of bronchiolitis in infants and children: a systematic review. Arch Pediatr Adolesc Med 2004; 158: 127-137 (Pubitemid 38173966)
14. Tal G, Cesar K, Oron A, Houri S, Ballin A, Mandelberg A. Hypertonic saline/epinephrine treatment in hospitalized infants with viral bronchiolitis reduces hospitalization stay: 2 years experience. IMAJ Isr Med Assoc J 2006; 8: 169-173
15. Mallory MD, Shay DK, Garrett J, Bordley WC. Bronchiolitis management preferences and the influence of pulse oximetry and respiratory rate on the decision to admit. Pediatrics 2003; 111: e45-51.
16. Simoes EAF. Immunoprophylaxis of respiratory syncytial virus: global experience. Respir Res 2002; 3(Suppl 1): S26-33.
17. Simoes EAF, Carbonell-Estray X, Fullarton JR, et al. A predictive model for respiratory syncytial virus (RSV) hospitalization of premature infants born at 33-35 weeks of gestational age based on data from the Spanish Flip study. Respir Res 2008; 9: 78.